Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.
2.

Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.

Chang SJ, Bristow RE, Ryu HS.

Ann Surg Oncol. 2012 Dec;19(13):4059-67. doi: 10.1245/s10434-012-2446-8. Epub 2012 Jul 6.

PMID:
22766983
3.

Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer.

Zhao D, Wu LY, Wang XB, Li XG.

Asian Pac J Cancer Prev. 2015;16(6):2369-73.

4.

Perioperative morbidity and mortality in octogenarians with ovarian cancer.

Walters CL, Schneider KE, Whitworth JM, Fauci JM, Smith HJ, Barnes MN, Straughn JM.

Int J Gynecol Cancer. 2013 Jul;23(6):1006-9. doi: 10.1097/IGC.0b013e3182980fac.

PMID:
23714708
5.

Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.

Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J.

Ann Surg Oncol. 2013 Apr;20(4):1348-54. doi: 10.1245/s10434-012-2673-z. Epub 2012 Oct 2.

PMID:
23054114
6.

Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.

Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD.

Int J Gynecol Cancer. 2012 Jun;22(5):778-85. doi: 10.1097/IGC.0b013e31824d836c.

PMID:
22572845
7.

Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.

Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B, Chereau E, Bergzoll C, Querleu D.

Int J Gynecol Cancer. 2012 Oct;22(8):1337-43.

PMID:
22964527
8.

Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer.

Kommoss S, Rochon J, Harter P, Heitz F, Grabowski JP, Ewald-Riegler N, Haberstroh M, Neunhoeffer T, Barinoff J, Gomez R, Traut A, du Bois A.

Ann Surg Oncol. 2010 Jan;17(1):279-86. doi: 10.1245/s10434-009-0787-8. Epub 2009 Nov 7.

PMID:
19898901
9.

Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.

Risum S, Loft A, Engelholm SA, Høgdall E, Berthelsen AK, Nedergaard L, Lundvall L, Høgdall C.

Int J Gynecol Cancer. 2012 Sep;22(7):1163-9.

PMID:
22810969
10.

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.

Zang RY, Harter P, Chi DS, Sehouli J, Jiang R, Tropé CG, Ayhan A, Cormio G, Xing Y, Wollschlaeger KM, Braicu EI, Rabbitt CA, Oksefjell H, Tian WJ, Fotopoulou C, Pfisterer J, du Bois A, Berek JS.

Br J Cancer. 2011 Sep 27;105(7):890-6. doi: 10.1038/bjc.2011.328. Epub 2011 Aug 30.

11.

Dualistic classification of epithelial ovarian cancer: surgical and survival outcomes in a large retrospective series.

Panici PB, Marchetti C, Salerno L, Musella A, Vertechy L, Palaia I, Perniola G, Ruscito I, Boni T, Angioli R, Muzii L.

Ann Surg Oncol. 2014 Sep;21(9):3036-41. doi: 10.1245/s10434-014-3714-6. Epub 2014 Apr 28.

PMID:
24770721
12.

Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.

Bacalbasa N, Dima S, Brasoveanu V, David L, Balescu I, Purnichescu-Purtan R, Popescu I.

World J Surg Oncol. 2015 Aug 5;13:235. doi: 10.1186/s12957-015-0652-0.

13.

Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.

Gadducci A, Cosio S, Zola P, Sostegni B, Fuso L, Sartori E.

Int J Gynecol Cancer. 2013 Mar;23(3):461-8. doi: 10.1097/IGC.0b013e318286665b.

PMID:
23370604
15.

Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures.

Tentes AA, Mirelis CG, Markakidis SK, Bekiaridou KA, Bougioukas IG, Xanthoulis AI, Tsalkidou EG, Zafiropoulos GH, Nikas IH.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):490-5.

PMID:
16681716
16.

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.

Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA.

Oncology. 2013;84(3):158-65. doi: 10.1159/000341366. Epub 2012 Dec 28.

PMID:
23296063
17.

Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?

Rocconi RP, Sullivan P, Long B, Blaize M, Brown J, Arbuckle J, Bevis K, Estes JM, Reed E, Finan MA.

Int J Gynecol Cancer. 2012 Jun;22(5):786-91. doi: 10.1097/IGC.0b013e31825104f4.

PMID:
22552832
18.

Outcome of Epithelial Ovarian Cancer: Time for Strategy Trials to Resolve the Problem of Optimal Timing of Surgery.

Van de Putte G, Oben J, Prenen L, Schobbens JC, Vlasselaer J, Van Holsbeke C, Debrock G, Van Eycken P, de Jonge E.

Int J Gynecol Cancer. 2015 Jul;25(6):993-9. doi: 10.1097/IGC.0000000000000461.

PMID:
25914962
19.

Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.

Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, Hartkopf A, Trope C, Kimmig R, Krawczyk N, Wallwiener D, Wimberger P, Kasimir-Bauer S.

Int J Gynecol Cancer. 2013 Jun;23(5):839-45. doi: 10.1097/IGC.0b013e3182907109.

PMID:
23694981
20.

Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer.

McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A.

Ann Surg Oncol. 2011 Oct;18(10):2912-8. doi: 10.1245/s10434-011-1661-z. Epub 2011 Mar 22.

PMID:
21424880
Items per page

Supplemental Content

Write to the Help Desk